From immunomodulatory drugs to microRNA therapy
Inflammatory bowel disease (IBD) refers to a group of chronic intestinal inflammatory conditions, primarily ulcerative colitis (UC) and Crohn’s disease (CD). These autoimmune mucosal damage conditions cause pain, bloating, indigestion, and acute abdominal emergencies, significantly reducing quality of life in the long term. Newer treatments have emerged based on a better understanding of the pathophysiology […]
Study points to potential use of cholesterol-lowering drugs to treat aggressive colorectal tumors
Hard-to-detect colorectal precancerous lesions known as serrated polyps and the aggressive tumors that develop from them are linked to increased production of cholesterol, according to preclinical studies by Weill Cornell Medicine researchers. It depends a lot. This finding points to the possibility of using cholesterol-lowering drugs to prevent or treat such tumors. In the study, […]
Ozempic, Wegovy and other GLP-1 drugs may help prevent colorectal cancer
GLP-1, a type of diabetes and weight loss drug such as Ozempic and Mounjaro, may be associated with a lower risk of colorectal cancer, but more research is needed. Researchers looked at the records of more than 1.2 million diabetic patients and compared GLP-1 to other common anti-diabetic drugs such as metformin and insulin. In […]
Weight loss drugs may help reduce risk
Share on PinterestResearchers are studying the possibility that weight loss drugs can reduce the risk of colorectal cancer.Victor Torres/Stoshi Researchers report that certain type 2 diabetes drugs, which are also used for weight loss, may reduce the risk of colorectal cancer. Obesity and diabetes are both risk factors for colorectal cancer. Maintaining a healthy weight, […]
Types of diabetes drugs that may prevent the development of colorectal cancer
Credit: Dr_Microbe/Getty Images Researchers at Case Western Reserve University say certain diabetes drugs used to treat type 2 diabetes may reduce the risk of developing colorectal cancer (CRC). These drugs, called glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, are drugs given by injection that lower blood sugar levels, improve insulin sensitivity, and help with weight […]
Harvard Health Ad Watch: Why are there toilets everywhere in this drug’s ads?
If the primary purpose of advertising a drug is to attract attention; This ad for Entyvio (vedolizumab) works. A young woman is seen getting into a car, sitting in a cubicle at work, sitting in a restaurant, and finally in the waiting room of a doctor’s office. But she’s not sitting in a car seat […]